Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Stock Traders Daily
$20.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

YM BioSciences Inc Announces Receipt of Final Court Order Approving Plan of Arrangement with Gilead Sciences Inc


Tuesday, 5 Feb 2013 10:47am EST 

YM BioSciences Inc announced that the Supreme Court of Nova Scotia has issued a final order approving the previously announced plan of arrangement (the Arrangement) involving the Company, Gilead Sciences Inc (Gilead) and 3268218 Nova Scotia Limited, a wholly-owned subsidiary of Gilead (the Purchaser). Under the Arrangement, the Purchaser will acquire all of the issued and outstanding common shares (Common Shares) of the Company for cash consideration of USD2.95 per Common Share. In addition, holders of warrants and options will each receive a cash payment equal to the difference between USD2.95 and the exercise price of such warrants or options. Assuming all other closing conditions are satisfied or waived, it is anticipated that the Arrangement will become effective on February8, 2013 (the "Effective Date"). 

Company Quote

105.96
0.03 +0.03%
19 Sep 2014